132 related articles for article (PubMed ID: 459556)
1. Cancer of the breast. Nursing care.
Krumm S
Major Probl Clin Surg; 1979; 5():587-612. PubMed ID: 459556
[No Abstract] [Full Text] [Related]
2. Advances in chemotherapy options for metastatic breast cancer: introduction of epothilones.
McGee L
ONS Connect; 2007; 22(8 Suppl):29-30. PubMed ID: 17824553
[No Abstract] [Full Text] [Related]
3. Estrogen receptor: a valid test for selection of breast cancer patients for endocrine ablation.
Leung BS; Fletcher WS; Krippaehne WW
Surg Forum; 1973; 24():125-7. PubMed ID: 4142813
[No Abstract] [Full Text] [Related]
4. Clinical studies in advanced breast cancer.
Forrest AP
J R Coll Surg Edinb; 1967 Apr; 12(3):192-206. PubMed ID: 6045735
[No Abstract] [Full Text] [Related]
5. [Endocrine treatment of mammary carcinoma].
NOGUES AE
Medicina (B Aires); 1957; 17(5-6):255-68. PubMed ID: 13565063
[No Abstract] [Full Text] [Related]
6. Defining the endocrine and metabolic aspects of cancer.
Tashima CK
Geriatrics; 1977 Oct; 32(10):53-5, 58-63, 68-9. PubMed ID: 908513
[No Abstract] [Full Text] [Related]
7. High-dose chemotherapy and autologous bone marrow support for breast cancer.
Peters WP
Important Adv Oncol; 1991; ():135-50. PubMed ID: 1869274
[No Abstract] [Full Text] [Related]
8. [The chemotherapy of breast cancer].
Obrecht JP; Hartmann D; Della Pietra C
Ther Umsch; 1976 Dec; 33(12):808-14. PubMed ID: 797038
[No Abstract] [Full Text] [Related]
9. Breast cancer: dreaded diagnosis, complicated care.
Dest VM; Fisher SM
RN; 1994 Jun; 57(6):48-54; quiz 55. PubMed ID: 7973391
[No Abstract] [Full Text] [Related]
10. Chemotherapy and endocrine therapy in metastatic disease.
Pritchard KI
Curr Opin Oncol; 1989 Dec; 1(2):324-32. PubMed ID: 2489975
[No Abstract] [Full Text] [Related]
11. [Current modalities for breast cancer treatment].
Sviatukhina OV
Vestn Akad Med Nauk SSSR; 1980; (5):50-7. PubMed ID: 6994393
[No Abstract] [Full Text] [Related]
12. [Lysozyme and cytostatic therapy].
Neretto G; Giovanelli E; Agricola R; Pellegrino S; Bruno F; Mangione M; Furno F
Clin Ter; 1978 Dec; 87(5):465-73. PubMed ID: 737983
[No Abstract] [Full Text] [Related]
13. [The hormone and chemotherapy in female metastatic breast cancer (author's transl)].
Obrecht JP; Nagel GA; Mayr AC
Schweiz Rundsch Med Prax; 1974 Jan; 63(4):109-14. PubMed ID: 4411163
[No Abstract] [Full Text] [Related]
14. [Study of long surviving patients after treatment of thoracic metastases of breast neoplasms by combined hormone therapy and nonhormonal antineoplastic drug therapy from the onset].
Mannes P; Derriks R; Moens R
Lille Med; 1972 May; 17(5):762-4. PubMed ID: 4626798
[No Abstract] [Full Text] [Related]
15. [Treatment of breast cancer].
Zornoza G; Clemente JL; de Oca J; Goena I; Fakih A
Rev Med Univ Navarra; 1982 Mar; 26(1):15-22. PubMed ID: 7111947
[No Abstract] [Full Text] [Related]
16. Hormonal therapy for breast cancer.
Dunne CF
Cancer Nurs; 1988 Oct; 11(5):288-94. PubMed ID: 3233579
[No Abstract] [Full Text] [Related]
17. [Nursing care in adverse effects of chemotherapy].
Simonetti G
Tijdschr Ziekenverpl; 1981 Jul; 34(15):644-50. PubMed ID: 6913266
[No Abstract] [Full Text] [Related]
18. [Therapy of metastatic breast cancer].
Eidtmann H; Jonat W
Ther Umsch; 1993 May; 50(5):352-8. PubMed ID: 7690992
[TBL] [Abstract][Full Text] [Related]
19. Difficulties designing clinical trials as exemplified by a phase 2 drug evaluation of 5(3,3-bis(2-chloroethyl)-1-triazenol)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in patients with disseminated breast cancer.
Ahmann DL; Bisel HF; Hahn RG
Cancer Res; 1973 Jul; 33(7):1707-10. PubMed ID: 4578655
[No Abstract] [Full Text] [Related]
20. An autopsy study of metastatic sites of breast cancer.
Viadana E; Cotter R; Pickren JW; Bross ID
Cancer Res; 1973 Jan; 33(1):179-81. PubMed ID: 4682319
[No Abstract] [Full Text] [Related]
[Next] [New Search]
